Format

Send to

Choose Destination
Inflamm Res. 2011 Jan;60(1):79-86. doi: 10.1007/s00011-010-0238-9. Epub 2010 Aug 20.

Human skin penetration of a copper tripeptide in vitro as a function of skin layer.

Author information

1
Department of Dermatology, UCSF School of Medicine, San Francisco, CA, USA. jurij.hostynek65@gmail.com

Erratum in

  • Inflamm Res. 2011 Jun;60(6):611.

Abstract

OBJECTIVE AND DESIGN:

Skin retention and penetration by copper applied as glycyl-L-histidyl-L-lysine cuprate diacetate was evaluated in vitro in order to assess its potential for its transdermal delivery as an anti-inflammatory agent.

MATERIALS AND METHODS:

Flow-through diffusion cells with 1 cm(2) exposure area were used under infinite dose conditions. 0.68% aq. copper tripeptide as permeant was applied on isolated stratum corneum, heat-separated epidermis and dermatomed skin and receptor fluid collected over 48 h in 4 h intervals using inductively coupled plasma mass spectrometry to analyze for copper in tissues and receptor fluid.

RESULTS:

The permeability coefficient of the compound through dermatomed skin was 2.43 ± 0.51 × 10(-4) cm/h; 136.2 ± 17.5 μg/cm(2) copper permeated 1 cm(2) of that tissue over 48 h, while 97 ± 6.6 μg/cm(2) were retained as depot.

CONCLUSIONS:

Copper as tripeptide was delivered in potentially therapeutically effective amounts for inflammatory disease.

PMID:
20721598
PMCID:
PMC3016279
DOI:
10.1007/s00011-010-0238-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center